AU648097B2 - New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin IIB - Google Patents

New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin IIB Download PDF

Info

Publication number
AU648097B2
AU648097B2 AU82239/91A AU8223991A AU648097B2 AU 648097 B2 AU648097 B2 AU 648097B2 AU 82239/91 A AU82239/91 A AU 82239/91A AU 8223991 A AU8223991 A AU 8223991A AU 648097 B2 AU648097 B2 AU 648097B2
Authority
AU
Australia
Prior art keywords
date
document
pristinamycin
international
sulphonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU82239/91A
Other languages
English (en)
Other versions
AU8223991A (en
Inventor
Jean-Claude Barriere
Jean-Pierre Corbet
Jean-Marc Paris
Xavier Radisson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU8223991A publication Critical patent/AU8223991A/en
Application granted granted Critical
Publication of AU648097B2 publication Critical patent/AU648097B2/en
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Request to Amend Deed and Register Assignors: RHONE-POULENC RORER S.A.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AU82239/91A 1990-07-16 1991-07-15 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin IIB Expired AU648097B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR909009037A FR2664600B1 (fr) 1990-07-16 1990-07-16 Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
FR9009037 1990-07-16
PCT/FR1991/000582 WO1992001694A1 (fr) 1990-07-16 1991-07-15 Nouveaux sels derives de la dialcoylaminoalcoylsulfonyl-26 pristinamycine ii¿b?

Publications (2)

Publication Number Publication Date
AU8223991A AU8223991A (en) 1992-02-18
AU648097B2 true AU648097B2 (en) 1994-04-14

Family

ID=9398755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82239/91A Expired AU648097B2 (en) 1990-07-16 1991-07-15 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin IIB

Country Status (20)

Country Link
US (1) US5326782A (enExample)
EP (1) EP0539460B1 (enExample)
JP (1) JP3345814B2 (enExample)
KR (1) KR100199066B1 (enExample)
AT (1) ATE112570T1 (enExample)
AU (1) AU648097B2 (enExample)
CA (1) CA2086925C (enExample)
DE (1) DE69104485T2 (enExample)
DK (1) DK0539460T3 (enExample)
ES (1) ES2061259T3 (enExample)
FI (1) FI100970B (enExample)
FR (1) FR2664600B1 (enExample)
IE (1) IE64068B1 (enExample)
IL (1) IL98854A (enExample)
NZ (1) NZ238949A (enExample)
PT (1) PT98337B (enExample)
RU (1) RU2081119C1 (enExample)
TW (1) TW228523B (enExample)
WO (1) WO1992001694A1 (enExample)
ZA (1) ZA915445B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664598A1 (fr) * 1990-07-16 1992-01-17 Rhone Poulenc Rorer Sa Procede de preparation de sulfinyl pristinamycine iib.
FR2766489B1 (fr) 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
GB9801741D0 (en) * 1998-01-27 1998-03-25 Inst Biomar Sa New cytotoxic tris (oxazole)-containing macrolides
US6432954B1 (en) 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6743812B1 (en) 2000-07-14 2004-06-01 Targacept, Inc. Pharmaceutical compositions and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
GB8616768D0 (en) * 1986-07-09 1986-08-13 May & Baker Ltd Process
ATE74926T1 (de) * 1987-07-07 1992-05-15 Rhone Poulenc Sante Verfahren zur herstellung von derivaten von pristinamycin iib.
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof

Also Published As

Publication number Publication date
ES2061259T3 (es) 1994-12-01
CA2086925A1 (fr) 1992-01-17
IE64068B1 (en) 1995-07-12
KR100199066B1 (ko) 1999-06-15
AU8223991A (en) 1992-02-18
RU2081119C1 (ru) 1997-06-10
PT98337B (pt) 1999-01-29
WO1992001694A1 (fr) 1992-02-06
JP3345814B2 (ja) 2002-11-18
FI930166L (fi) 1993-01-15
IL98854A (en) 1995-11-27
PT98337A (pt) 1992-05-29
US5326782A (en) 1994-07-05
FI100970B (fi) 1998-03-31
DE69104485T2 (de) 1995-02-23
JPH05508652A (ja) 1993-12-02
IE912448A1 (en) 1992-01-29
FI930166A0 (fi) 1993-01-15
KR930701451A (ko) 1993-06-11
EP0539460A1 (fr) 1993-05-05
DE69104485D1 (de) 1994-11-10
DK0539460T3 (da) 1994-11-07
FR2664600B1 (fr) 1994-09-02
IL98854A0 (en) 1992-07-15
TW228523B (enExample) 1994-08-21
ATE112570T1 (de) 1994-10-15
ZA915445B (en) 1992-04-29
NZ238949A (en) 1992-09-25
CA2086925C (fr) 2002-12-10
FR2664600A1 (fr) 1992-01-17
EP0539460B1 (fr) 1994-10-05

Similar Documents

Publication Publication Date Title
EP2477991B1 (en) Process for preparing azabicyclic compounds
ES2363196T3 (es) Derivados de diosmetina, su procedimiento de preparación y composiciones farmacéuticas que los contienen.
WO1994022872A1 (fr) Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine
OA13357A (en) Azabenzofuran substituted thioureas as inhibitors of viral replication.
EP0526642A1 (en) Triterpene derivative
EP0288973A2 (en) Benzothiazolinone derivatives, their production and pharmaceutical composition
JPH01503233A (ja) 製薬活性化合物
KR930001835B1 (ko) 신규 히단토인(Hydantoin) 유도체의 제조방법
AU2005266493B2 (en) Inhibitors of Hsp90
JP7677912B2 (ja) ジアリールアミド化合物及びそれらの用途
CA2022236A1 (en) Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
CN116406364A (zh) 用于治疗红细胞障碍和炎性疾病的四氢异喹啉衍生物
US5326782A (en) Salts derived from 26-(dialkylaminoalkylsulphonyl)pristinamycin IIB
CA3039070A1 (en) Inhibitors of mtor-deptor interactions and methods of use thereof
WO2016206576A1 (zh) 一种氘代噻吩并哌啶衍生物、制备方法及其应用
CN120202002A (zh) 一种用于癌症治疗的药物组合物
KR900006745B1 (ko) 5-아미노-1,2-디티올-3-온 화합물 및 그의 제법
CA1251449A (en) TETRAHYDRO-.beta.-CARBOLINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
GB2295825A (en) Pharmaceutical compositions
RU2017737C1 (ru) Способ получения изоксазоловых производных
PT831092E (pt) Derivado de hidroquinona e a sua aplicacao farmaceutica
WO1997004783A2 (en) Bis-1-oxaquinolizidine alkaloids from a marine sponge with antitumor activity
CA2035988A1 (en) Imidazole compounds, processes for their preparation, pharmaceuticals based on these compounds and some intermediaes
EP2012776A2 (en) 9a-substituted azalides
WO2009003307A1 (fr) Dérivés de phtiobuzonum et préparation, composition pharmaceutique et utilisation de ceux-ci

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER NAME WAS: RHONE-POULENC RORER S.A.